Sistema cardiovascolare

Anti-B2M/beta 2-Microglobulin Antibody (8H120) is a Mouse antibody targeting B2M/beta 2-Microglobulin. Anti-B2M/beta 2-Microglobulin Antibody (8H120) can be used in ELISA, IHC.

Anti-AFP Antibody (2P399) is a Mouse antibody targeting AFP. Anti-AFP Antibody (2P399) can be used in ELISA, IHC.

Anti-ARNT Antibody (1Z917) is an antibody targeting ARNT. Anti-ARNT Antibody (1Z917) can be used in ELISA, WB, IHC, IP.

Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) is an antibody targeting Apolipoprotein A-II/APOA2. Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) can be used in ELISA, WB, IHC, FCM.

<p>Anti-RBP4 Antibody (7V2) is a Mouse antibody targeting RBP4. Anti-RBP4 Antibody (7V2) can be used in ELISA, WB, IHC.</p>

Anti-Podoplanin Antibody (6Y710) is an antibody targeting Podoplanin. Anti-Podoplanin Antibody (6Y710) can be used in ELISA.

Anti-COX-2 Antibody (5V841) is an antibody targeting COX-2. Anti-COX-2 Antibody (5V841) can be used in ELISA.

Anti-NT5E Antibody (8O943) is an antibody targeting NT5E. Anti-NT5E Antibody (8O943) can be used in ELISA, IHC.

Anti-Myoglobin Antibody (6W871) is a Mouse antibody targeting Myoglobin. Anti-Myoglobin Antibody (6W871) can be used in ELISA, WB, IHC, IF.

Anti-TSPO Antibody (8L560) is an antibody targeting TSPO. Anti-TSPO Antibody (8L560) can be used in ELISA, WB, IHC, IF, FCM, IP.

Anti-NPPA Antibody (9Q284) is an antibody targeting NPPA. Anti-NPPA Antibody (9Q284) can be used in ELISA.

Anti-SAA1 Antibody (8H152) is an antibody targeting SAA1. Anti-SAA1 Antibody (8H152) can be used in ELISA, FCM.

Anti-MMP-9 Antibody (5B504) is an antibody targeting MMP-9. Anti-MMP-9 Antibody (5B504) can be used in ELISA, IHC, FCM.

Anti-LMO2 Antibody (3P24) is an antibody targeting LMO2. Anti-LMO2 Antibody (3P24) can be used in ELISA, WB.

Anti-NT5E Antibody (3G418) is an antibody targeting NT5E. Anti-NT5E Antibody (3G418) can be used in ELISA, IHC, FCM.

Anti-PLAU/uPA Antibody (1K616) is an antibody targeting PLAU/uPA. Anti-PLAU/uPA Antibody (1K616) can be used in ELISA, IHC.

Anti-LYVE1 Antibody (5P861) is an antibody targeting LYVE1. Anti-LYVE1 Antibody (5P861) can be used in ELISA, IF, FCM.

Anti-HAMP Antibody (7O537) is an antibody targeting HAMP. Anti-HAMP Antibody (7O537) can be used in ELISA, WB, IHC.

<p>AG-1478 (NSC-693255) (Tyrphostin AG-1478) is a selective EGFR inhibitor.</p>

<p>BAY 41-8543 is a nitric oxide (NO)-independent stimulator of soluble guanylyl cyclase (sGC).</p>

PHPS1 blocks Shp2, halts Shp2-E76K-induced Erk1/2 activation, and stops tumor cell growth.

Moexipril hydrochloride (Moexipril HCl) is a potent orally active nonsulfhydrylangiotensin converting enzyme (ACE)inhibitor, used for the treatment of

Pyraclostrobin is one of the most heavily used fungicides that inhibits mitochondrial complex III of fungal and mammalian cells.

T0901317 is a potent and selective agonist for both LXR and FXR, with EC50 of ~50 nM and 5 μM, respectively; it inhibits nuclear factor/κB (NF/κB).

NFAT Inhibitor-2 is a compound used as a molecular building block.

<p>Cinacalcet metabolite M4 (Rarechem AL BW 1078) is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.</p>

<p>1. Loganic acid (Loganate) and geniposide exhibit both sides effect on superoxide generation.</p>

Gadolinium chloride is a calcium-sensing receptor (CaSR) agonist

BI-0115 inhibits LOX-1, preventing oxLDL uptake by triggering receptor inhibition and dimer formation.

Magnesium Lithospermate B is a derivative of caffeic acid tetramer. Magnesium Lithospermate B inhibits neuroinflammation and reduces neurodegeneration.

Anagliptin (SK-0403) is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.

α-Linolenic Acid (ALA) is an essential fatty acid. α-Linolenic acid improves memory, inhibits thrombosis, and lowers blood lipids. Cost-effective and quality-assured.

GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.

Clematichinenoside AR is anti-inflammatory, immunosuppressive, and combats arthritis via PI3K/Akt and TNF-α pathways.

N-(p-Coumaroyl) Serotonin, from safflower seeds, has antioxidant, antitumor properties and improves vascular health.

Delapril HCl (indalapril) is a prodrug forming two ACE inhibitors, blocking angiotensin I-II conversion.

IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expression

Dofetilide (UK 68789), a class III antiarrhythmic sulfonamide, blocks Ikr cardiac channels, prolongs action potential, and treats atrial fibrillation/flutter.

Emodin 6-O-β-D-glucoside (Glucoemodin) can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses.

Cynaroside (Luteolin 7-O-Glucoside) is a flavone, a flavonoid-like chemical compound. It has an anti-oxidant effect, inhibiting lipid and protein oxidation.

GR 125743 is a novel antagonist of 5-HT1B/1D receptor.

PD-161570 is a potent and ATP-competitive human FGF-1 receptor inhibitor with an IC50 of 39.9 nM and a Ki of 42 nM.

<p>Tri-Salicylic Acid, a product of the thermal decomposition of aspirin, is a compound for proteomics research.</p>

Ethyl linoleate is a natural product and can inhibit the expression of inflammatory mediators and the development of atherosclerotic lesions.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human NT-ProBNP, and the Human NT-ProBNP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human NT-ProBNP. After TMB substrate solution is added, only those wells that contain Human NT-ProBNP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human NT-ProBNP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human IGFBP1, and the Human IGFBP1 standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human IGFBP1. After TMB substrate solution is added, only those wells that contain Human IGFBP1 and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human IGFBP1 in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Rat ADP, and the Rat ADP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Rat ADP. After TMB substrate solution is added, only those wells that contain Rat ADP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Rat ADP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Lpa, and the Human Lpa standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human Lpa. After TMB substrate solution is added, only those wells that contain Human Lpa and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Lpa in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human ADP, and the Human ADP standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human ADP. After TMB substrate solution is added, only those wells that contain Human ADP and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human ADP in the samples is then determined by comparing the OD of the samples to the standard curve.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human TIMP1, and the Human TIMP1 standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human TIMP1. After TMB substrate solution is added, only those wells that contain Human TIMP1 and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human TIMP1 in the samples is then determined by comparing the OD of the samples to the standard curve.